0.60Open0.60Pre Close0 Volume1.24K Open Interest7.50Strike Price0.00Turnover244.48%IV7.51%PremiumJul 19, 2024Expiry Date0.04Intrinsic Value100Multiplier2DDays to Expiry0.56Extrinsic Value100Contract SizeAmericanOptions Type-0.4714Delta0.2735Gamma12.43Leverage Ratio-0.1416Theta-0.0003Rho-5.86Eff Leverage0.0024Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$